Human hepatocyt: I. Model for the study of xenobiotic metabolism and toxicity;Lidsky hepatocyt: I. Model pro studium metabolizmu a toxicity xenobiotik

Ceska a Slovenska Farmacie

Volumn 48, Issue 2, 1999, Pages 65-71

  Kosina, Pavel ^a,b   Dvorak Z ^a   Walterova D ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b NONE   (Czech Republic)

Author keywords

Human hepatocyte; Isolation; Metabolism; Primary cultures; Xenobiotics

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CHLORZOXAZONE; COUMARIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOCHROME P450; DEBRISOQUINE; DEXAMETHASONE; DEXTROMETHORPHAN; DIETHYLDITHIOCARBAMIC ACID; ERYTHROMYCIN; GESTODENE; KETOCONAZOLE; LANSOPRAZOLE; MEPHENYTOIN; NIFEDIPINE; OMEPRAZOLE; ORPHENADRINE; PACLITAXEL; PHENACETIN; PHENOBARBITAL; PILOCARPINE; PROPRANOLOL; QUINIDINE; RIFAMPICIN; SULFAPHENAZOLE; TROLEANDOMYCIN; UNINDEXED DRUG; WARFARIN; ANTINEOPLASTIC AGENT; XENOBIOTIC AGENT;

ANIMAL CELL; BIOTRANSFORMATION; DRUG CYTOTOXICITY; DRUG METABOLISM; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIVER CELL CULTURE; LIVER METABOLISM; NONHUMAN; RAT; REVIEW; XENOBIOTIC METABOLISM; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; LIVER; TOXICITY TESTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELLS, CULTURED; HUMANS; LIVER; PACLITAXEL; RATS; TOXICITY TESTS; XENOBIOTICS;

EID: 0033092034     PISSN: 12107816     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Oesch, F., Diener, B.: Pharmacol. Toxicol. 76, 325 (1995).
2. Ulrich, R. G., Bacon, J. A., Cramer, C. T. et al.: Toxicol. Lett. 107, 82 (1995).
3. Hawksworth, G. M.: Hum. Exp. Toxicol. 13, 568 (1994).
4. Moshage, H., Yap, S. H.: J. Hepatol. 15, 404 (1992).
5. Mabit, H., Vons, C., Dubanchet, S. et al.: J. Hepatol. 24, 403 (1996).
6. Fabre, G., Combalbert, J., Berger, Y., Cano, J. P.: Eur. J. Drug Metab. Pharmacokinet. 15, 165 (1990).
7. Kvasničková, E., Šroler, A., Nobilis, M.: Českoslov. Farm. 37, 272 (1988).
8. Liddiard, C., Merker, H. J., Nau, H.: Arch. Toxicol. 44, 107 (1980).
9. Guguen-Guillouzo, C., Campion, J. P., Brissot, D.: Cell. Biol. Int. Rep. 6, 625 (1982).
10. Strom, S. C., Jirtle, R. L., Jones, R. S.: J. Natl. Cancer Inst. 68, 771 (1982).
11. Guillouzo, A.: Cell Biol. Toxicol. 11, 141 (1995).
12. Guillouzo, A., Morel, F., Fardel, O., Meunier, B.: Toxicology 82, 209 (1993).
13. Morel, F., Beaune, P. H., Ratanasavanh, D. et al.: Eur. J. Biochem. 191, 437 (1990).
14. Butterworth, B. E:, Smith-Oliver, T., Earle, L. et al.: Cancer. Res. 49, 1075 (1989).
15. Skett, P., Tyson, Ch., Guillouzo, A., Maier, P.: Biochem. Pharmacol. 50, 280 (1995).
16. Chesné, Ch., Guyomard, C., Fautrel, A. et al.: Hepatology 18, 406 (1993).
17. Reese, J. A., Byard, J. L.: In Vitro 17, 935 (1981).
18. Ballet, F., Bouma, M.-E., Wang, S.-R. et al.: Hepatology 218, 13 (1984).
19. Gómez-Lechón, M. J., López, P., Donato, T. et al.: In Vitro Cell. Dev. Biol. 26, 67 (1990).
20. Wiebkin, P., Dees, J. H., Mathis, J. M., Prough, R. A.: Drug. Metab. Dispos. 13, 163 (1985).
21. Gugen-Guillouzo, C.: In: Culture of epithelial Cells, Wiley-Liss, London 1992, s. 197.
22. Dou, M., De Sousa, G., Lacarelle, B. et al.: Cryobiology 29, 454 (1992).
23. Condouris, J. A., Grant, M. H., Engeset, J. et al.: Xenobiotica 23, 1399 (1993).
24. Thomas, P., De Sousa, G., Nicola, F. et al.: Transpl. Int. 8, 426 (1995).
25. Československý lékopis 4, s. 46, Avicenum, Praha 1987.
26. United States Federal Standard 209E, Sept. 1992.
27. Drobník, J. et al.: In: Mezinárodní pravidla pro práci v chemických a biologických laboratořích. Karolinum, Praha 1995.
28. Schlesing, H.: In: Accreditation and Quality Assurance in Analytical Chemistry (Gunzler, H., ed.). Springer-Verlag, Berlin, Heidelberg, New York 1994, s. 229.
29. Zákon č. 79/1997 Sb., o léčivech a o změnách a doplnění některých souvisejících zákonů.
30. Berry, M. N., Friend, D. S.: J. Cell Biol. 43, 17 (1969).
31. Seglen, P. O.: In: Methods in Cell Biology (Prescott, D. M., ed.), Vol 13. Academic Press, New York 1976, s. 29.
32. Houssin, D., Capron, M., Celier, C. et al.: Life Sci. 33, 1805 (1983).
33. Sandker, G. W., Vos, R. M. E., Delbressine, L. P. C. et al.: Xenobiotica 24, 143 (1994).
34. Moshage, H. J., Rjintjes, P. J., Hafkenscheid, J. C. et al.: J. Hepatol. 7, 34 (1988).
35. Koebe, H.-G., Pehernik, S., Eyer, P., Schildberg, F.-W.: Xenobiotica 24, 95 (1994).
36. Bader, A., Zech, K., Crome, O. et al.: Xenobiotica 24, 623 (1994).
37. Bader, A., Rinkes, I. H. B., Closs, I. E. et al.: Biotechnol. Prog. 8, 219 (1992).
38. Trautwein, CH., Davies, M., Elias, E. et al.: J. Hepatol. 22, 50 (1995).
39. Bissel, D. M., Arenson, D. M., Maher, J. J. et al.: J. Clin. Invest. 79, 801 (1987).
40. Farghali, H., Kameníková, L., Hynie, S.: Physiol. Res. 43, 117 (1994).
41. Farghali, H., Kameníková, L., Martínek, J. et al.: Physiol. Res. 43, 121 (1994).
42. Farghali, H., Hynie, S.: In: Methods in Biotechnology, Vol. 1: Immobilization of Enzymes and Cells (Bickerstaff, G. F., ed.). Humana Press Inc., Totowa, NJ, 1997, s. 175.
43. Hynie, S., Farghali, H., Kameníková, L.: In: Methods in Biotechnology, Vol. 1: Immobilization of Enzymes and Cells (Bickerstaff, G. F., ed.). Humana Press Inc., Totowa, NJ, 1997, s. 185.
44. Kameníková, L., Farghali, H., Mišeková, D. et al.: Physiol. Res. 43, 127 (1994).
45. Hynie, S., Křen, V., Bílá, V. et al.: Physiol. Res. 43, 131 (1994).
46. Fourneau, I., Depla, E., van Pelt, J. et al.: In: Bioartificial Liver Support Systems. The Critical Issues (Weyhenmeyer, J., ed.), CIC Edizioni Internazionali, 1997, s. 62.
47. Begue, J. M., Le Bigot, J. F., Guguen-Guillouzo, Ch. et al.: Biochem. Pharmacol. 32, 1643 (1983).
48. Roberts, E. A., Letarte, M., Squire, J., Yang, S.: Hepatology 19, 1390 (1994).
49. Gibson-D'Ambrosio, R. E., Crowe, D. L., Sculer, C. E., D'Ambrosio, S. M.: Cell Biol. Toxicol. 9, 395 (1993).
50. Doostdar, H., Duthie, S. J., Burke, M. D. et al.: FEBS Lett. 241, 15 (1988).
51. Strange, J., Mitzner, S., Strauss, M. et al.: Asaio J. 41, 310 (1995).
52. In: Cell & Tissue Culture: Laboratory Procedures. (Doyle, A., Griffiths, J. B., Newell, D. G., eds.), John Willey & Sons ltd., Chichester 1996.
53. Bergmeyer, H. U.: In: Methods of Enzymatic Analysis, Vol. 1 (Bergmeyer, H. U., ed.). Verlag Chemie GmbH, Weinhein/Bergstr. 1974, s. 481.
54. Gutmann, I., Bergmeyer, H. U.: In: Methods of Enzymatic Analysis, Vol. 4 (Bergmeyer, H. U., ed.). Verlag Chemie GmbH, Weinhein/Bergstr. 1974, s. 1794.
55. Cobbold, P. H., Rink, T. J.: Biochem. J. 248, 313 (1987).
56. Thomas, P. A., Delaville, F.: In: Cellular Calcium - A Practical Approach (McCormack, J. G., Cobbold, P. H., ed.). Oxford Univ. Press, 1991, s. 1.
57. Maurel, P.: Advanced Drug Delivery Reviews 22, 105 (1996).
58. Correia, M. A.: In: Cytochrome P450 Structure, Mechanism, and Biochemistry (de Montellano, P.R.O., ed.) Plenum Press, New York 1995, s. 619.
59. Donato, M. T., Gomez-Lechon, M. J., Castell, J. V.: In: In Vitro Alternatives to Animal Pharmacotoxicology (Castell, J. V., Gomez-Lechon, M. J., eds.). Farmaindustria, Madrid 1992, s. 149.
60. Pryor, W. A.: Free Radic. Biol. Med. 7, 177 (1989).
61. Janero, D. R.: Free Radic. Biol. Med. 9, 515 (1990).
62. Bernt, E., Bergmeyer, H. U.: In: Methods of Enzymatic Analysis, Vol. 4 (Bergmeyer, H. U., ed.). Verlag Chemie GmbH, Weinhein/Bergstr. 1974, s. 1643.
63. Walle, T., Kumar, G. N., McMillan, J. M. et al.: Biochem. Pharmacol. 46, 1661 (1993).
64. Kostrubsky, V. E., Lewis, L. D., Wood, S. G. et al.: Toxicol. Appl. Pharmacol. 142, 79 (1997).
65. Walle, T. In: Methods in Enzymology (Johnson, E. F., Waterman, M. R., eds.). Vol. 272, Academic Press 1996, s., 145.